ADMA Biologics, Inc. (ADMA)
10.31
+0.13
(+1.28%)
USD |
NASDAQ |
Oct 13, 16:00
10.31
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Total Return Price : 10.31 for Oct. 13, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| October 13, 2026 | 10.31 |
| October 12, 2026 | 10.18 |
| October 09, 2026 | 10.36 |
| October 08, 2026 | 10.33 |
| October 07, 2026 | 10.14 |
| October 06, 2026 | 10.18 |
| October 05, 2026 | 10.11 |
| October 02, 2026 | 9.72 |
| October 01, 2026 | 9.93 |
| September 30, 2026 | 10.03 |
| September 29, 2026 | 9.96 |
| September 28, 2026 | 10.12 |
| September 25, 2026 | 9.38 |
| September 24, 2026 | 9.52 |
| September 23, 2026 | 9.70 |
| September 22, 2026 | 9.81 |
| September 21, 2026 | 9.505 |
| September 18, 2026 | 9.11 |
| September 17, 2026 | 8.95 |
| September 16, 2026 | 8.90 |
| September 15, 2026 | 8.61 |
| September 14, 2026 | 9.14 |
| September 11, 2026 | 9.23 |
| September 10, 2026 | 9.39 |
| September 09, 2026 | 9.45 |
| Date | Value |
|---|---|
| September 08, 2026 | 9.54 |
| September 04, 2026 | 9.62 |
| September 03, 2026 | 9.58 |
| September 02, 2026 | 9.51 |
| September 01, 2026 | 9.33 |
| August 31, 2026 | 9.39 |
| August 28, 2026 | 9.34 |
| August 27, 2026 | 9.48 |
| August 26, 2026 | 9.63 |
| August 25, 2026 | 9.72 |
| August 24, 2026 | 9.55 |
| August 21, 2026 | 9.84 |
| August 20, 2026 | 9.76 |
| August 19, 2026 | 10.05 |
| August 18, 2026 | 9.54 |
| August 17, 2026 | 9.34 |
| August 14, 2026 | 9.47 |
| August 13, 2026 | 9.41 |
| August 12, 2026 | 9.78 |
| August 11, 2026 | 9.905 |
| August 10, 2026 | 9.75 |
| August 07, 2026 | 9.90 |
| August 06, 2026 | 10.06 |
| August 05, 2026 | 9.26 |
| August 04, 2026 | 8.91 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Vericel Corp. | 40.30 |
| BioMarin Pharmaceutical, Inc. | 54.38 |
| Emergent BioSolutions, Inc. | 6.91 |
| Exelixis, Inc. | 59.51 |
| Akebia Therapeutics, Inc. | 0.77 |